ENTRADA THERAPEUTICS INC

Ticker: TRDA CUSIP: 29384C108 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,632,460 Value ($000) $16,782 Avg Close Range
Q3 2025
Shares 1,604,225 Value ($000) $9,305 Avg Close Range
Q2 2025
Shares 1,604,860 Value ($000) $10,785 Avg Close Range
Q1 2025
Shares 1,575,594 Value ($000) $14,243 Avg Close Range
Q4 2024
Shares 1,464,237 Value ($000) $25,317 Avg Close Range
Q3 2024
Shares 1,223,185 Value ($000) $19,546 Avg Close Range
Q2 2024
Shares 1,129,623 Value ($000) $16,097 Avg Close Range
Q1 2024
Shares 1,078,908 Value ($000) $15,288 Avg Close Range
Q4 2023
Shares 1,065,166 Value ($000) $16,073 Avg Close Range
Q3 2023
Shares 1,020,317 Value ($000) $16,121 Avg Close Range
Q2 2023
Shares 1,009,749 Value ($000) $15,288 Avg Close Range
Q1 2023
Shares 928,665 Value ($000) $13,466 Avg Close Range
Q4 2022
Shares 920,253 Value ($000) $12,442 Avg Close Range
Q3 2022
Shares 870,147 Value ($000) $13,714 Avg Close Range
Q2 2022
Shares 762,364 Value ($000) $9,285 Avg Close Range
Q1 2022
Shares 430,404 Value ($000) $4,041 Avg Close Range
Q4 2021
Shares 424,952 Value ($000) $7,274 Avg Close Range